24,25-epoxycholesterol has been researched along with 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate in 1 studies
Studies (24,25-epoxycholesterol) | Trials (24,25-epoxycholesterol) | Recent Studies (post-2010) (24,25-epoxycholesterol) | Studies (4-o-methyl-12-o-tetradecanoylphorbol 13-acetate) | Trials (4-o-methyl-12-o-tetradecanoylphorbol 13-acetate) | Recent Studies (post-2010) (4-o-methyl-12-o-tetradecanoylphorbol 13-acetate) |
---|---|---|---|---|---|
65 | 0 | 18 | 156 | 1 | 44 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, AJ; Quinn, CM; Wong, J | 1 |
1 other study(ies) available for 24,25-epoxycholesterol and 4-o-methyl-12-o-tetradecanoylphorbol 13-acetate
Article | Year |
---|---|
Statins inhibit synthesis of an oxysterol ligand for the liver x receptor in human macrophages with consequences for cholesterol flux.
Topics: ATP Binding Cassette Transporter 1; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; Cell Differentiation; Cell Line; Cholesterol; DNA-Binding Proteins; Gene Expression Regulation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ligands; Liver X Receptors; Lovastatin; Macrophages; Monocytes; Orphan Nuclear Receptors; Receptors, Cytoplasmic and Nuclear; Tetradecanoylphorbol Acetate | 2004 |